Development of high-affinity nanobodies specific for NaV1.4 and NaV1.5 voltage-gated sodium channel isoforms

• Published in: The Journal of biological chemistry Vol. 298; no. 4; p. 101763
• Main Authors: Srinivasan, Lakshmi, Alzogaray, Vanina, Selvakumar, Dakshnamurthy, Nathan, Sara, Yoder, Jesse B., Wright, Katharine M., Klinke, Sebastián, Nwafor, Justin N., Labanda, María S., Goldbaum, Fernando A., Schön, Arne, Freire, Ernesto, Tomaselli, Gordon F., Amzel, L. Mario, Ben-Johny, Manu, Gabelli, Sandra B.
• Format: Journal Article
• Language: English
• Published: United States Elsevier Inc 01.04.2022; American Society for Biochemistry and Molecular Biology
• Subjects: Biochemistry & Molecular Biology; biolayer interferometry; FRET; hIPSC-CM; Lama glama; nanobody; NaV1.4; NaV1.5; voltage-gated sodium channel; X-ray diffraction; dd; Ab; RT; TES; FL; biolayer interferometry; HRP; X-ray diffraction; voltage-gated sodium channel; hIPSC-CM; CaM; PDB; BSA; DMEM; HEK293; Nb; T; DSC; hiPSC; VHH; FRET; cDNA; Ni; PBL; CDR3; NaV; Lama glama; GST; CM; nanobody; NaV1.4; NIH; NaV1.5; SEC; CT; PBST; HA; NTA; TN; BLI
• ISSN: 0021-9258; 1083-351X
• DOI: 10.1016/j.jbc.2022.101763

Voltage-gated sodium channels, NaVs, are responsible for the rapid rise of action potentials in excitable tissues. NaV channel mutations have been implicated in several human genetic diseases, such as hypokalemic periodic paralysis, myotonia, and long-QT and Brugada syndromes. Here, we generated high-affinity anti-NaV nanobodies (Nbs), Nb17 and Nb82, that recognize the NaV1.4 (skeletal muscle) and NaV1.5 (cardiac muscle) channel isoforms. These Nbs were raised in llama (Lama glama) and selected from a phage display library for high affinity to the C-terminal (CT) region of NaV1.4. The Nbs were expressed in Escherichia coli, purified, and biophysically characterized. Development of high-affinity Nbs specifically targeting a given human NaV isoform has been challenging because they usually show undesired crossreactivity for different NaV isoforms. Our results show, however, that Nb17 and Nb82 recognize the CTNaV1.4 or CTNaV1.5 over other CTNav isoforms. Kinetic experiments by biolayer interferometry determined that Nb17 and Nb82 bind to the CTNaV1.4 and CTNaV1.5 with high affinity (KD ∼ 40–60 nM). In addition, as proof of concept, we show that Nb82 could detect NaV1.4 and NaV1.5 channels in mammalian cells and tissues by Western blot. Furthermore, human embryonic kidney cells expressing holo NaV1.5 channels demonstrated a robust FRET-binding efficiency for Nb17 and Nb82. Our work lays the foundation for developing Nbs as anti-NaV reagents to capture NaVs from cell lysates and as molecular visualization agents for NaVs.